Gabapentin dementia
Pro Research Analysisby 
Searched over 200M research papers for "gabapentin dementia"
Gabapentin and Dementia: A Comprehensive Overview
Gabapentin for Behavioral and Psychological Symptoms of Dementia (BPSD)
Efficacy and Safety Profile
Gabapentin, an antiepileptic agent, is increasingly considered for treating Behavioral and Psychological Symptoms of Dementia (BPSD) due to its favorable safety profile compared to other psychiatric medications. Several case reports and series suggest that gabapentin is well-tolerated and effective in managing BPSD in geriatric patients 134. However, the data is limited, and no controlled studies have been published to date, which restricts the robust support for its off-label use .
Case Studies and Retrospective Reviews
In a retrospective chart review involving 24 patients with dementia, gabapentin was found to significantly improve aggressive and agitated behaviors, with 17 out of 22 patients showing marked improvement . Another study involving 20 patients with probable Alzheimer’s disease and serious comorbidities reported that gabapentin was efficacious and well-tolerated, reducing caregiver stress and showing no serious adverse events .
Limitations and Concerns
Despite these positive findings, there are concerns regarding the appropriateness of gabapentin for all types of dementia-related agitation. For instance, two case reports questioned its use in patients with dementia with Lewy bodies . Additionally, a study involving 12 patients with severe behavioral disorders found that while gabapentin was generally well-tolerated, it did not significantly change behavioral scores for most patients .
Gabapentin and Risk of Dementia
Increased Risk of Dementia
A large-scale, population-based study from Taiwan found that gabapentin or pregabalin use is associated with an increased risk of dementia. The study reported a multivariate-adjusted hazard ratio of 1.45 for dementia risk in patients exposed to these drugs compared to non-exposed patients . The risk was notably higher in younger patients under 50 years of age .
Neurocognitive Changes in Older Adults
Gabapentin initiation in older adults with initially normal cognition has been linked to significant neurocognitive changes, including cognitive and functional status decline, and increased falls . This raises concerns about the safety of gabapentin in older adults, particularly those with normal cognition at baseline.
Utilization Trends and Concurrent Medication Use
Increasing Use Among Older Adults
Gabapentin use among older adults has been increasing over the years, with a notable prevalence in those with dementia. Concurrent use of gabapentin with other potentially inappropriate medications, such as opioids and benzodiazepines, is also common, which could compound the risk of adverse effects .
Conclusion
Gabapentin shows promise in treating BPSD, particularly in patients who do not respond to conventional therapies. However, its use is not without risks, including an increased risk of dementia and neurocognitive decline in older adults. The current evidence is primarily based on case reports and retrospective studies, highlighting the need for controlled trials to better understand the efficacy and safety of gabapentin in this population. Clinicians should exercise caution and consider individual patient profiles when prescribing gabapentin for dementia-related symptoms.
Sources and full results
Most relevant research papers on this topic
Use of Gabapentin in the Treatment of Behavioural and Psychological Symptoms of Dementia
Gabapentin shows potential as a well-tolerated and effective treatment for behavioral and psychological symptoms of dementia, but more controlled studies are needed for clinical indication.
The association between Gabapentin or Pregabalin use and the risk of dementia: an analysis of the National Health Insurance Research Database in Taiwan
Gabapentin or pregabalin use is associated with an increased risk of dementia, particularly in younger patients.
A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias.
Gabapentin effectively reduces aggressive and agitated behaviors in nursing home patients with dementia, with no significant side effects observed in up to 2 years of treatment.
DOI